Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic initiation factor 4A-III (EIF4A3) is a central member of the DEAD-box RNA helicase family, recognized as the core RNA-binding component of the exon junction complex (EJC)[1][5][7]. EIF4A3 binds to mRNAs upstream of exon-exon boundaries after splicing in the nucleus, facilitating processes such as nonsense-mediated mRNA decay, mRNA export, and surveillance[1][4][5][7]. It acts as an essential scaffold for EJC assembly and for recruiting factors mediating RNA stability, transport, and translation regulation[1][7]. EIF4A3 plays critical roles in cell cycle control, stem cell pluripotency, ribosomal RNA (rRNA) processing, and tumor cell growth[2][3][6][7]. Overexpression of EIF4A3 has been linked to increased tumor cell proliferation and poor prognosis in various cancers; it is considered a tractable vulnerability in high ribosome biogenesis tumors[6]. EIF4A3 is also hijacked by certain viruses, such as influenza A, to promote viral RNA splicing and export[4]. Therapeutic inhibition of EIF4A3 is currently experimental and poses challenges due to the enzyme’s essential housekeeping roles in normal proliferative cells[7].
Inhibition of RNA helicase activity; Inhibition of exon junction complex deposition/function; Disruption of nonsense-mediated mRNA decay; Modulation of RNA stress granule dynamics
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic initiation factor 4A-III (EIF4A3).